Phreesia, Inc. (NYSE:PHR) Insider Yvonne Hui Sells 388 Shares

Phreesia, Inc. (NYSE:PHR) insider Yvonne Hui sold 388 shares of the firm’s stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $27.85, for a total transaction of $10,805.80. Following the completion of the sale, the insider now owns 26,517 shares of the company’s stock, valued at $738,498.45. The trade was a 1.44 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.

Yvonne Hui also recently made the following trade(s):

• On Tuesday, October 15th, Yvonne Hui sold 2,791 shares of Phreesia stock. The shares were sold at an average price of $20.92, for a total value of $58,387.72.

Phreesia Price Performance

PHR stock opened at $27.12 on Thursday. The stock has a 50-day moving average price of $23.18 and a two-hundred day moving average price of $22.71. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $29.16. The stock has a market cap of $1.58 billion, a PE ratio of -18.45 and a beta of 0.94. The company has a current ratio of 1.74, a quick ratio of 1.77 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. The business had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. Phreesia’s quarterly revenue was up 16.6% on a year-over-year basis. During the same period last year, the company earned ($0.58) earnings per share. Equities analysts forecast that Phreesia, Inc. will post -1.16 EPS for the current fiscal year.

Institutional Trading of Phreesia

Hedge funds and other institutional investors have recently made changes to their positions in the business. International Assets Investment Management LLC boosted its holdings in Phreesia by 2,179.7% during the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after purchasing an additional 1,395 shares during the last quarter. Lombard Odier Asset Management USA Corp acquired a new position in shares of Phreesia during the 2nd quarter worth about $202,000. Point72 DIFC Ltd acquired a new position in shares of Phreesia during the 2nd quarter worth about $209,000. XTX Topco Ltd bought a new position in shares of Phreesia in the 3rd quarter valued at about $247,000. Finally, Hsbc Holdings PLC acquired a new stake in shares of Phreesia in the second quarter valued at about $301,000. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

PHR has been the subject of a number of recent research reports. KeyCorp boosted their price target on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 8th. Needham & Company LLC restated a “buy” rating and issued a $29.00 price target on shares of Phreesia in a research report on Friday, January 10th. Citigroup increased their target price on Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, January 10th. JMP Securities restated a “market outperform” rating and set a $30.00 target price on shares of Phreesia in a report on Tuesday, December 10th. Finally, Truist Financial upped their price target on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Twelve analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $31.00.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.